Literature DB >> 15389575

Evidence of reciprocal regulation between the high extracellular calcium and RANKL signal transduction pathways in RAW cell derived osteoclasts.

Jiake Xu1, Cathy Wang, Renzhi Han, Nathan Pavlos, Tony Phan, James H Steer, Anthony J Bakker, David A Joyce, Ming H Zheng.   

Abstract

During bone resorption, osteoclasts are exposed to high Ca2+ concentrations (up to 40 mM). The role of high extracellular Ca2+ in receptor activator of NF-kappaB ligand (RANKL)-mediated osteoclast survival and their functional interrelationship is unclear. In this study, we show that RANKL enhances osteoclast tolerance to high extracellular Ca2+ by protecting the cell from cell death in a dose dependent manner. We have provided evidence that RANKL does this by attenuating high extracellular Ca2+-induced Ca2+ elevations. Moreover, we have found that high extracellular Ca2+-induced cell death was partially inhibited by a caspase-3 inhibitor, suggesting caspase-3-mediated apoptosis is involved. Conversely, using reporter gene assays and Western blot analysis, we have demonstrated that high extracellular Ca2+ desensitizes the RANKL-induced activation of NF-kappaB and c-Jun N-terminal kinase (JNK), and inhibits constitutive and RANKL-stimulated ERK phosphorylation, indicating a negative feed-back mechanism via specific RANKL signaling pathways. Taken together, this study provides evidence for a reciprocal regulation between high extracellular Ca2+ and RANKL signaling in RAW cell derived osteoclasts. Our data imply a cross talk mechanism of extracellular Ca2+ on osteoclast survival through the regulation of RANKL. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389575     DOI: 10.1002/jcp.20159

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.

Authors:  Kirk H M Yip; Haotian Feng; Nathan J Pavlos; Ming H Zheng; Jiake Xu
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  Choline kinase β mutant mice exhibit reduced phosphocholine, elevated osteoclast activity, and low bone mass.

Authors:  Jasreen Kular; Jennifer C Tickner; Nathan J Pavlos; Helena M Viola; Tamara Abel; Bay Sie Lim; Xiaohong Yang; Honghui Chen; Robert Cook; Livia C Hool; Ming Hao Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

3.  Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells.

Authors:  Ramanaiah Mamillapalli; Joshua VanHouten; Walter Zawalich; John Wysolmerski
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

4.  Interleukin-1 induces receptor activator of nuclear factor-κB ligand-independent osteoclast differentiation in RAW264.7 cells.

Authors:  Rongdong Liao; Zhuoxi Feng; Wei Li; Rubing Liu; Xinrou Xu; Shun Yao; Jing Tian
Journal:  Exp Ther Med       Date:  2021-04-16       Impact factor: 2.447

5.  Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases.

Authors:  Maurizio Bossù; Patrizia Mancini; Erika Bruni; Daniela Uccelletti; Adele Preziosi; Marco Rulli; Michela Relucenti; Orlando Donfrancesco; Flavia Iaculli; Gianni Di Giorgio; Roberto Matassa; Alessandro Salucci; Antonella Polimeni
Journal:  Biology (Basel)       Date:  2021-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.